{
    "2021-10-29": [
        [
            {
                "time": "2021-11-04",
                "original_text": "Novo Nordisk Boosts FY21 Outlook After Solid Q3 Sales",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "FY21 Outlook",
                        "Solid Q3 Sales"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-04",
                "original_text": "Novo Nordisk raises sales and operating profit outlook for 2021",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "sales outlook",
                        "operating profit",
                        "2021"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}